Evidence map›Paper›PMID 37587013›Full record

ArticleJournal of industrial microbiology & biotechnology2023

Utilizing a divalent metal ion transporter to control biogenic nanoparticle synthesis.

Manasi Subhash Gangan, Kyle L Naughton, James Q Boedicker

Open access · goldAbstract read
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Manasi Subhash GanganDepartment of Physics and Astronomy, University of Southern California, Los Angeles, CA 90089, USA.
Kyle L NaughtonDepartment of Physics and Astronomy, University of Southern California, Los Angeles, CA 90089, USA.
James Q BoedickerDepartment of Physics and Astronomy, University of Southern California, Los Angeles, CA 90089, USA.ORCID 0000-0003-4107-3719
University of Southern California · US

Funding

Naval Research Multidisciplinary University Research Initiative N00014-18-1-2632
6 · The paper itself

Abstract

Biogenic synthesis of inorganic nanomaterials has been demonstrated for both wild and engineered bacterial strains. In many systems the nucleation and growth of nanomaterials is poorly controlled and requires concentrations of heavy metals toxic to living cells. Here, we utilized the tools of synthetic biology to engineer a strain of Escherichia coli capable of synthesizing cadmium sulfide nanoparticles from low concentrations of reactants with control over the location of synthesis. Informed by simulations of bacterially-assisted nanoparticle synthesis, we created a strain of E. coli expressing a broad-spectrum divalent metal transporter, ZupT, and a synthetic CdS nucleating peptide. Expression of ZupT in the outer membrane and placement of the nucleating peptide in the periplasm focused synthesis within the periplasmic space and enabled sufficient nucleation and growth of nanoparticles at sub-toxic levels of the reactants. This strain synthesized internal CdS quantum dot nanoparticles with spherical morphology and an average diameter of approximately 3.3 nm. ONE-SENTENCE SUMMARY: Expression of a metal ion transporter regulates synthesis of cadmium sulfide nanoparticles in bacteria.

Indexed as

Cadmium CompoundsNanoparticlesEscherichia coliMembrane Transport ProteinsSulfidesCadmium Compoundscadmium sulfideMembrane Transport ProteinsSulfidesBiosynthesisCadmium sulfideMetal ion transportNanoparticlesSynthetic biology

Identifiers

PMID37587013
PMCPMC10481092
OpenAlexW4385898122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.